PURPOSE: The time interval between last childbirth and subsequent breast cancer diagnosis is emerging as an important prognostic factor for premenopausal women. PATIENTS AND METHODS: We studied, prospectively, 750 women diagnosed with primary invasive breast cancer before age 45 years who participated in the population-based Australian Breast Cancer Family Study (ABCFS). RESULTS: Median follow-up time was 4.9 years (range, 0.8 to 10.8 years). Compared with nulliparous women, women who gave birth within 2 years prior to diagnosis were more likely to have axillary node-positive (58% v 41%; P =.01), and estrogen receptor-negative (58% v 39%; P =.005) tumors. The unadjusted hazard ratios for death were 2.3 (95% CI, 1.3 to 3.8; P =.002), 1.7 (95% CI, 1.1 to 2.6; P =.03), and 0.9 (95% CI, 0.6 to 1.5; P =.8) for patients who gave birth less than 2 years, 2 to 5 years, and 5 or more years before diagnosis, respectively. After adjusting for tumor characteristics, these hazard ratios were reduced to 1.9 (95%CI, 1.1 to 3.2; P =.02), 1.3 (95% CI, 0.8 to 2.1; P =.3), and 0.9 (95%CI, 0.5 to 1.4; P =.5). Modeling showed that, compared with nulliparous women, the mortality hazard ratio in parous women was 1.9, decreasing by 8% (95%CI, 4% to 13%; P <.001) for each year between last birth and breast cancer diagnosis. CONCLUSION: Proximity of last childbirth to subsequent breast cancer diagnosis is a predictor of mortality independent of histopathological tumor characteristics. Clinicians should be aware that women diagnosed with breast cancer within a few years following childbirth may have a worse outcome than that suggested solely by the standard histopathological prognostic factors of their cancer.
PURPOSE: The time interval between last childbirth and subsequent breast cancer diagnosis is emerging as an important prognostic factor for premenopausal women. PATIENTS AND METHODS: We studied, prospectively, 750 women diagnosed with primary invasive breast cancer before age 45 years who participated in the population-based Australian Breast Cancer Family Study (ABCFS). RESULTS: Median follow-up time was 4.9 years (range, 0.8 to 10.8 years). Compared with nulliparous women, women who gave birth within 2 years prior to diagnosis were more likely to have axillary node-positive (58% v 41%; P =.01), and estrogen receptor-negative (58% v 39%; P =.005) tumors. The unadjusted hazard ratios for death were 2.3 (95% CI, 1.3 to 3.8; P =.002), 1.7 (95% CI, 1.1 to 2.6; P =.03), and 0.9 (95% CI, 0.6 to 1.5; P =.8) for patients who gave birth less than 2 years, 2 to 5 years, and 5 or more years before diagnosis, respectively. After adjusting for tumor characteristics, these hazard ratios were reduced to 1.9 (95%CI, 1.1 to 3.2; P =.02), 1.3 (95% CI, 0.8 to 2.1; P =.3), and 0.9 (95%CI, 0.5 to 1.4; P =.5). Modeling showed that, compared with nulliparous women, the mortality hazard ratio in parous women was 1.9, decreasing by 8% (95%CI, 4% to 13%; P <.001) for each year between last birth and breast cancer diagnosis. CONCLUSION: Proximity of last childbirth to subsequent breast cancer diagnosis is a predictor of mortality independent of histopathological tumor characteristics. Clinicians should be aware that women diagnosed with breast cancer within a few years following childbirth may have a worse outcome than that suggested solely by the standard histopathological prognostic factors of their cancer.
Authors: Marilyn L Kwan; Philip S Bernard; Candyce H Kroenke; Rachel E Factor; Laurel A Habel; Erin K Weltzien; Adrienne Castillo; Erica P Gunderson; Kaylynn S Maxfield; Inge J Stijleman; Bryan M Langholz; Charles P Quesenberry; Lawrence H Kushi; Carol Sweeney; Bette J Caan Journal: J Natl Cancer Inst Date: 2015-04-28 Impact factor: 13.506
Authors: Jenean O'Brien; Traci Lyons; Jenifer Monks; M Scott Lucia; R Storey Wilson; Lisa Hines; Yan-gao Man; Virginia Borges; Pepper Schedin Journal: Am J Pathol Date: 2010-01-28 Impact factor: 4.307
Authors: Kathrin Strasser-Weippl; Ritesh Ramchandani; Lei Fan; Junjie Li; Marc Hurlbert; Dianne Finkelstein; Zhi-Ming Shao; Paul E Goss Journal: Breast Cancer Res Treat Date: 2014-12-14 Impact factor: 4.872
Authors: Kelly-Anne Phillips; Richard H Osborne; Graham G Giles; Gillian S Dite; Carmel Apicella; John L Hopper; Roger L Milne Journal: J Clin Oncol Date: 2008-10-01 Impact factor: 44.544
Authors: Katherine I Morley; Roger L Milne; Graham G Giles; Melissa C Southey; Carmel Apicella; John L Hopper; Kelly-Anne Phillips Journal: Aust N Z J Public Health Date: 2010-04 Impact factor: 2.939
Authors: Kelly-Anne Phillips; Roger L Milne; Dee W West; Pamela J Goodwin; Graham G Giles; Ellen T Chang; Jane C Figueiredo; Michael L Friedlander; Theresa H M Keegan; Gord Glendon; Carmel Apicella; Frances P O'Malley; Melissa C Southey; Irene L Andrulis; Esther M John; John L Hopper Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254
Authors: Xuezheng Sun; Hazel B Nichols; Chiu-Kit Tse; Mary B Bell; Whitney R Robinson; Mark E Sherman; Andrew F Olshan; Melissa A Troester Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-06 Impact factor: 4.254